Tenon Medical Inc. Receives FDA Clearance for Expanded Use of Catamaran® SI Joint Fusion System in Spinal Fusion Procedures

Reuters
06-12
Tenon Medical Inc. Receives FDA Clearance for Expanded Use of Catamaran® SI Joint Fusion System in Spinal Fusion Procedures

Tenon Medical Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded indication for the use of their Catamaran® SI Joint Fusion System. This approval allows the system to be used to augment immobilization and stabilization of the sacroiliac (SI) joint for patients undergoing sacropelvic fixation as part of a lumbar fusion. The company believes this regulatory milestone will open a substantial new market opportunity by addressing the need for robust SI joint stabilization in complex spinal fusion procedures. This expanded indication aims to enhance patient care for those suffering from SI joint disorders by providing a dependable and efficient method for authentic SI joint fusion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenon Medical Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1038579) on June 12, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10